R&D investment continues to soar particularly in the clinical space, with large pharma investing more now than ever. Pharma giants such as Merck, Roche, and Johnson & Johnson were amongst the top of the list of 2024 R&D spenders. Despite geopolitical headwinds associated with the rising cost of China tariffs and the unprecedented future of administration policies, it's evident that procurement teams are ensuring R&D continues.

The 9th R&D Procurement & Sourcing in Pharma Summit returns with reimagined strategic and implementation procurement tracks dedicated to you and the team to transform wider and day-to-day operations. Uniting 100+ biopharma procurement professionals, we will be uncovering AI-driven efficiency, insights to help develop teams from the ground up, and tips to remain agile in light of an externally changing market.